Home
Live Updates
Repare Therapeutics to Present Initial Phase 1 MINOTAUR Data at ESMO GI Congress 2024 : comparemela.com
Repare Therapeutics to Present Initial Phase 1 MINOTAUR Data at ESMO GI Congress 2024
Repare Therapeutics Inc. , a leading clinical-stage precision oncology company, announced initial data from the Phase 1 MINOTAUR study evaluating lunresertib in combination with FOLFIRI for the...
Related Keywords
Germany ,
Munich ,
Bayern ,
Lunresertib Lunre ,
Zeva Wainberg ,
Repare Therapeutics Inc ,
European Society Of Medical Oncology ,
Linkedin ,
Twitter ,
Gastrointestinal Gi Cancers Congress ,
Company Nasdaq ,
David Geffen School Of Medicine ,
Repare Therapeutics ,
European Society ,
Medical Oncology ,
Cancers Congress ,
Advanced Gastrointestinal ,
David Geffen School ,
comparemela.com © 2020. All Rights Reserved.